Divi's Laboratories to release quarterly, half-year financials November 7

Divi's Laboratories Limited announced its board of directors will convene on Friday, November 7, 2025. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year that concluded on September 30, 2025. This intimation was made to both the National Stock Exchange of India Limited and BSE Limited.

In accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the company had previously closed its trading window for dealing in securities. This closure commenced on October 1, 2025, following an intimation on September 30, 2025.

The trading window will remain closed until November 9, 2025, which is 48 hours after the declaration of the financial results. This measure ensures fair disclosure and prevents insider trading in anticipation of the financial announcement.